Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Dansk Kolinesterase Kartotek udreder patienter med forlænget paralyse efter suxamethon og mivacurium

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Søvnforstyrrelser hos børn og unge

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Selvmordsforebyggende klinikker for børn og unge med fokus på Region Hovedstaden

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Epidemiologi for alkoholrelateret leversygdom

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Skadelige konsekvenser af alkoholindtag blandt unge mennesker

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Genetisk screening af adopterede raske individer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. A retrospective observational study of neuromuscular monitoring practice in 30,430 cases from six Danish hospitals

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Barriers and aidsto routine neuromuscular monitoring and consistent reversal practice: - a qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Muskelrelaxantia

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  4. Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The Danish Cholinesterase Research Unit (DCRU) is a nationwide unit for patients carrying mutations in the butyrylcholinesterase enzyme (BChE). BChE hydrolyzes the neuromuscular blocking drugs succinylcholine and mivacurium. Patients with mutations in the butyrylcholinesterase gene are at risk of experiencing a prolonged effect of the drugs, such as weakness or paralysis for hours. In order to diagnose the referred patients correctly, DCRU combines results such as BChE activity, genotyping, pedigree and clinical reactions to succinylcholine or mivacurium.

Translated title of the contributionDanish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium
Original languageDanish
JournalUgeskrift for Laeger
Volume177
Issue number18
Pages (from-to)866-8
Number of pages3
ISSN0041-5782
Publication statusPublished - 27 Apr 2015

ID: 45903128